These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33108898

  • 1. Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension.
    Patel J, Patel K, Garg P, Patel S.
    Asian Cardiovasc Thorac Ann; 2021 Mar; 29(3):170-178. PubMed ID: 33108898
    [Abstract] [Full Text] [Related]

  • 2. Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension.
    Oztekin I, Yazici S, Oztekin DS, Goksel O, Issever H, Canik S.
    Yakugaku Zasshi; 2007 Feb; 127(2):375-83. PubMed ID: 17268158
    [Abstract] [Full Text] [Related]

  • 3. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
    Wang H, Gong M, Zhou B, Dai A.
    Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
    [Abstract] [Full Text] [Related]

  • 4. Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
    Eskandr AM, Metwally AA, Abu Elkassem MS, Sadik SA, Elmiligy AE, Mourad M, Hussein L.
    J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2540-2546. PubMed ID: 29880427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
    Kundra TS, Prabhakar V, Kaur P, Manjunatha N, Gandham R.
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2123-2129. PubMed ID: 30098861
    [Abstract] [Full Text] [Related]

  • 8. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K, Sbraga F, Bianco G, Speziale G, Gucciardo M, Sampognaro R, Ruvolo G.
    J Card Surg; 2005 Oct; 20(2):171-6. PubMed ID: 15725144
    [Abstract] [Full Text] [Related]

  • 9. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
    Fattouch K, Sbraga F, Sampognaro R, Bianco G, Gucciardo M, Lavalle C, Vizza CD, Fedele F, Ruvolo G.
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
    [Abstract] [Full Text] [Related]

  • 10. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A, Kumar B, Dutta V, Arya VK, Mishra AK.
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [Abstract] [Full Text] [Related]

  • 11. Underlying Rheumatic Disease: An Important Determinant of Outcome in Tricuspid Valve Repair.
    Munasur M, Naidoo D.
    J Heart Valve Dis; 2016 Mar; 25(2):203-210. PubMed ID: 27989068
    [Abstract] [Full Text] [Related]

  • 12. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
    Theodoraki K, Thanopoulos A, Rellia P, Leontiadis E, Zarkalis D, Perreas K, Antoniou T.
    Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
    [Abstract] [Full Text] [Related]

  • 13. Early hemodynamic changes after mitral valve replacement in patients with severe and mild pulmonary artery hypertension.
    Bayat F, Aghdaii N, Farivar F, Bayat A, Valeshabad AK.
    Ann Thorac Cardiovasc Surg; 2013 Dec; 19(3):201-6. PubMed ID: 23064658
    [Abstract] [Full Text] [Related]

  • 14. Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome?
    Walls MC, Cimino N, Bolling SF, Bach DS.
    J Heart Valve Dis; 2008 Jan; 17(1):1-9; discussion 9. PubMed ID: 18365562
    [Abstract] [Full Text] [Related]

  • 15. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
    Hachenberg T, Möllhoff T, Holst D, Hammel D, Brüssel T.
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
    [Abstract] [Full Text] [Related]

  • 16. Mitral valve replacement in severe pulmonary arterial hypertension.
    Mubeen M, Singh AK, Agarwal SK, Pillai J, Kapoor S, Srivastava AK.
    Asian Cardiovasc Thorac Ann; 2008 Jan; 16(1):37-42. PubMed ID: 18245704
    [Abstract] [Full Text] [Related]

  • 17. Perspectives on surgical treatment of mitral valve disease.
    David TE.
    Asian Cardiovasc Thorac Ann; 2020 Sep; 28(7):360-365. PubMed ID: 32469675
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right ventricular function and outcome after mitral valve replacement?
    Pande S, Agarwal SK, Dhir U, Chaudhary A, Kumar S, Agarwal V.
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):421-5. PubMed ID: 19497952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structural analysis of the mitral valve in rheumatic and degenerative mitral valve diseases: implications for annuloplasty selection.
    Li Y, Zhang H, Zhang H, Luo T, Wang J, Zhu Z, Han J, Li Y, Meng X.
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):617-623. PubMed ID: 31274274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.